Company Nascent Biotech, Inc. Other OTC
Equities
NBIO
US63108Q1013
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Sean Carrick
CEO | Chief Executive Officer | 56 | 15/14/15 |
Lowell Holden
DFI | Director of Finance/CFO | 82 | 15/14/15 |
Douglas Karas
BRD | Director/Board Member | 59 | 04/16/04 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Lowell Holden
DFI | Director of Finance/CFO | 82 | 15/14/15 |
Sean Carrick
CEO | Chief Executive Officer | 56 | 15/14/15 |
Douglas Karas
BRD | Director/Board Member | 59 | 04/16/04 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 169,729,565 | 101,841,640 ( 60.00 %) | 0 | 60.00 % |
Company contact information
Nascent Biotech, Inc.
623 US Highway 1 Suite 407
33408, North Palm Beach
+
http://www.nascentbiotech.com![address Nascent Biotech, Inc.(NBIO)](https://cdn.zonebourse.com/static/address/18088236.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+15.20% | 121B | |
+19.67% | 113B | |
+18.95% | 26.02B | |
-23.86% | 19.39B | |
-19.03% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |